Ketoprofen Dompé (Ketoprofen Lysine)

Ketoprofen lysine works by non‑selectively inhibiting the cyclooxygenase enzymes COX‑1 and COX‑2. This blocks the synthesis of prostaglandins, which are key mediators of inflammation, pain, and fever. By reducing prostaglandin levels, the drug diminishes the inflammatory response and the perception of pain.

The appropriate dose of Ketoprofen Dompé is determined by the prescribing healthcare professional based on the patient’s age, weight, severity of symptoms, and overall medical condition. Dosage regimens may vary, and patients should follow the specific instructions provided by their prescriber.

Safety data for ketoprofen lysine in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss use with their healthcare provider.

To order Ketoprofen Dompé, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Ketoprofen and ibuprofen belong to the same NSAID class and share a similar mechanism of COX inhibition. Ketoprofen is often considered more potent on a milligram‑per‑milligram basis, which may allow lower dosing for comparable analgesic effect. However, both carry similar gastrointestinal, renal, and cardiovascular risks, so choice depends on clinical response and tolerability.

Ketoprofen Dompé should be stored at ambient temperature, below 25 °C (77 °F). Keep the product in its original packaging, protect it from moisture, excessive heat, and direct sunlight to maintain stability and potency throughout its shelf life.

Ketoprofen Dompé is administered orally. The tablet should be swallowed whole with a full glass of water, preferably with food or milk to reduce gastrointestinal irritation. Patients should not crush, chew, or split the tablet unless specifically instructed by a healthcare professional.

The most serious risks include gastrointestinal bleeding or ulcer perforation, severe renal impairment, cardiovascular events such as heart attack or stroke, and rare but life‑threatening skin reactions like Stevens‑Johnson syndrome. Patients should be monitored for signs of these complications, especially during prolonged therapy.

Ketoprofen Dompé should be avoided in individuals with known hypersensitivity to ketoprofen or other NSAIDs, active peptic ulcer disease, severe heart failure, uncontrolled hypertension, significant renal or hepatic impairment, and in patients who have experienced serious cardiovascular events while using NSAIDs.